PUBLICATIONS & ABSTRACTS

ABSTRACT: Systematic Review of Clinical Utility and Longer-Term Follow-up of Afirma GEC Testing
Sat, Apr 2, 2016
Endo Society 98th Annual Meeting
Boston, MA

Impact of a gene expression classifier on the long-term management of patients with cytologically indeterminate thyroid nodules
Singer, J. et al.
Mar 2016
Current Medical Research & Opinion

A Genomic Alternative to Preoperatively Identify Medullary Thyroid Cancer in Thyroid Nodules with Indeterminate Cytology
Kloos, RT, et al.
Mar 2016
Thyroid

Has Afirma Gene Expression Classifier Testing Refined the Indeterminate Thyroid Category in Cytology?
Yang S, et al.
Feb 2016
Cancer Cytopathology

Long-Term Non-Operative Rate of Thyroid Nodules With Benign Results on the Afirma Gene Expression Classifier
Sipos JA, et al.
Jan 2016
Endocrine Practice (In press)

Afirma Benign Thyroid Nodules Show Similar Growth to Cytologically Benign Nodules During Follow Up
Angell TE, et al.
Sep 2015
The Journal of Clinical Endocrinology & Metabolism

Outcome of Thyroid Gene Expression Classifier Testing in Clinical Practice
Witt RL, et al.
Sep 2015
The Laryngoscope (Link to abstract only)

Multicenter Clinical Experience with the Afirma Gene Expression Classifier
Alexander EK, et al
Oct 2013
The Journal of Clinical Endocrinology & Metabolism (Link to abstract only)

A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation
Cibas ES, et. al.
Sep 2013
Annals of Internal Medicine

Does Addition of BRAF V600E Mutation Testing Modify Sensitivity or Specificity of the Afirma Gene Expression Classifier in Cytologically Indeterminate Thyroid Nodules?
Kloos RT, et al.
Mar 2013
The Journal of Clinical Endocrinology & Metabolism (Link to abstract only)

123